Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence (AI) company transforming oncology drug discovery and development, today announced the launch of an innovative AI-powered ...

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...

The company received USFDA approval for Doxorubicin Hydrochloride Injection, which will be use for the treatment of Ovarian Cancer, AIDS-Related Kaposi’s Sarcoma, and Multiple Myeloma.

Alembic Pharmaceuticals shares surged over 12 per cent after receiving USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injection, used to treat ovarian cancer, Kaposi Sarcoma, and ...

President Donald Trump has signed House Resolution 1 (H.R. 1), the final version of which does not impose a moratorium on state legislation governing the use of AI. The bill does, however, restore the ...

The buyer in this case is Alembic’s US subsidiary, Alembic Pharmaceuticals Inc., which will take over full ownership of Utility.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Doxil Liposome Injection, of Baxter Healthcare Corporation. Doxorubicin Hydrochloride Liposome Injection is ...

Vadodara: Alembic Pharma has appointed G Krishnan as the Chief Financial Officer (CFO) and Key Managerial Personnel of the ...

According to IQVIA, the market for Doxorubicin Hydrochloride Liposome Injection is estimated at $29 million for the twelve months ending March 2025.

Vadodara: Alembic Pharmaceuticals Inc., a wholly owned subsidiary of Alembic Pharmaceuticals Limited, has acquired a 100 ...

The Indian stock market opened flat on Monday, after Gift Nifty indicated a positive start of the Nifty and Sensex today.

From Torrent Pharma’s major acquisition of JB Chemicals to Adani Power’s massive order to BHEL, and Zomato co-founder Deepinder Goyal’s entry into aviation, several corporate updates are likely to ...